Efficacy and safety of intra-operative thromboprophylaxis with low-molecular-weight-heparin or heparin in patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trial

Thromb Res. 2024 Oct:242:109123. doi: 10.1016/j.thromres.2024.109123. Epub 2024 Aug 20.
No abstract available

Keywords: Colorectal cancer; Low-molecular-weight heparin; Neoplasia; Surgery; Thromboprophylaxis; Venous thromboembolism.

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Anticoagulants* / therapeutic use
  • Colorectal Neoplasms* / surgery
  • Female
  • Heparin* / adverse effects
  • Heparin* / therapeutic use
  • Heparin, Low-Molecular-Weight* / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Treatment Outcome
  • Venous Thromboembolism / etiology
  • Venous Thromboembolism / prevention & control

Substances

  • Heparin, Low-Molecular-Weight
  • Anticoagulants
  • Heparin